[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside].
Agolini
G
G
Cavallini
G M
GM
D000284:Administration, Oral; D003930:Diabetic Retinopathy / Q000175:diagnosis / Q000188:drug therapy; D004341:Drug Evaluation; D005451:Fluorescein Angiography; D006801:Humans; D006896:Hydroxyethylrutoside / Q000008:administration & dosage*; D008266:Macula Lutea; D008268:Macular Degeneration / Q000175:diagnosis / Q000188:drug therapy; D012164:Retinal Diseases / Q000175:diagnosis / Q000188:drug therapy; D012170:Retinal Vein Occlusion / Q000175:diagnosis / Q000188:drug therapy; D012171:Retinal Vessels; D012431:Rutin / Q000031:analogs & derivatives*
D006896:Hydroxyethylrutoside; D012431:Rutin
Terapia a lungo termine delle vasculopatie retiniche com somministrazione orale di alti dosaggi di O-(beta-idrossietil)-rutosidea.